中文名称 | (S)-4-甲基-N-((S)-1-(((S)-4-甲基-1-((R)-2-甲基氧基-2-基)-1-氧代戊烷-2-基)氨基)-1-氧代-3-苯基丙烷-2-基)-2-((S)-2-(2-吗啉乙酰氨基)-4-苯基丁胺基)戊酰胺;卡非佐米 |
---|---|
英文名称 | Carfilzomib (Synonyms: PR-171) |
CAS号 | 868540-17-4 |
分子式 | C40H57N5O7 |
分子量 | 719.91 |
MDL | MFCD11040997 |
外观 | White to off-white powder |
储存条件 | Dry, dark and at 0 - 4 ℃ for short term (days to weeks) or -20 ℃ for long term (months to years). |
Carfilzomib (PR-171) is an irreversible proteasome inhibitor with IC50 of <5 nM in ANBL-6 cells, displayed preferential in vitro inhibitory potency against the ChT-L activity in the β5 subunit, but little or no effect on the PGPH and T-L activities. Carfilzomib activates prosurvival autophagy and induces cell apoptosis.
This product is unstable in solution state. We recommend that you use it immediately.
© 2020-2024 凯立德生物医药技术(上海)有限公司 版权所有
沪ICP备15046197号-3
沪公网安备31011502007856号
Designed by Kuanersoft